Gut health supplement may calm inflammation in kidney dialysis patients
NCT ID NCT07694791
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This trial tests whether a daily capsule containing probiotics and prebiotics can lower inflammation and improve nutrition in adults with chronic kidney disease who are on peritoneal dialysis. Participants take either the synbiotic or a placebo for six months, with blood tests and checkups at the start, three months, and six months. The study measures changes in inflammation markers, gut-derived toxins, and infection rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Synbiotic (probiotics plus prebiotic fibers)
- What this could lead to
- If it works, this could point toward a simple, low-cost way to reduce inflammation and infection risk in people on peritoneal dialysis.
- What could go wrong
- This is a small, early-stage trial with only 60 participants. The supplement may not significantly lower inflammation or prevent infections, and individual results may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 4 AND 5) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Dr. José E. González, Centro Regional de Enfermedades Renales (CRER)
RECRUITINGMonterrey, Nuevo León, 64460, Mexico
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI tutor for kidney doctors: can a chatbot improve dialysis decisions?
- Thousands of kidney patients tracked to unlock better disease management
- Dialysis showdown: which method protects heart and bones best?
- Why kidney disease drains your strength: scientists probe muscle fatigue
- Why kidney patients feel so tired: muscle fatigue under the microscope
- Can a Nurse-Led program reverse frailty in dialysis patients?